| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents | 9 | 2026 | 682 | 2.210 |
Why?
|
| Cell Death | 6 | 2026 | 290 | 1.710 |
Why?
|
| Apoptosis | 7 | 2025 | 1109 | 1.680 |
Why?
|
| ErbB Receptors | 5 | 2026 | 127 | 1.480 |
Why?
|
| Signal Transduction | 12 | 2026 | 3152 | 1.340 |
Why?
|
| Genomics | 3 | 2024 | 394 | 1.190 |
Why?
|
| Cell Line, Tumor | 13 | 2026 | 1613 | 1.000 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2026 | 197 | 1.000 |
Why?
|
| DNA Damage | 5 | 2024 | 300 | 0.990 |
Why?
|
| RNA Polymerase II | 1 | 2025 | 88 | 0.900 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 593 | 0.860 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 74 | 0.760 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 81 | 0.750 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 218 | 0.740 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 471 | 0.720 |
Why?
|
| Software | 1 | 2025 | 395 | 0.700 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 801 | 0.690 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 923 | 0.680 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2020 | 24 | 0.670 |
Why?
|
| Biological Assay | 1 | 2021 | 59 | 0.660 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 59 | 0.650 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2020 | 18 | 0.640 |
Why?
|
| Optical Imaging | 1 | 2021 | 78 | 0.630 |
Why?
|
| Neoplasms | 5 | 2022 | 1415 | 0.590 |
Why?
|
| Stromal Cells | 1 | 2018 | 78 | 0.550 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 274 | 0.500 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1229 | 0.500 |
Why?
|
| Fibroblasts | 1 | 2018 | 421 | 0.490 |
Why?
|
| Systems Biology | 2 | 2015 | 36 | 0.480 |
Why?
|
| Humans | 29 | 2026 | 65536 | 0.440 |
Why?
|
| Interferon-beta | 1 | 2015 | 79 | 0.440 |
Why?
|
| Interferon-alpha | 1 | 2015 | 102 | 0.430 |
Why?
|
| Protein Binding | 2 | 2016 | 1651 | 0.430 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2024 | 449 | 0.420 |
Why?
|
| Phosphorylation | 2 | 2016 | 977 | 0.420 |
Why?
|
| Heme | 1 | 2014 | 30 | 0.420 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2024 | 574 | 0.400 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 235 | 0.400 |
Why?
|
| Drug Synergism | 3 | 2024 | 146 | 0.390 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 111 | 0.390 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 473 | 0.330 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 174 | 0.300 |
Why?
|
| Kinetics | 2 | 2021 | 768 | 0.290 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 788 | 0.270 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 62 | 0.270 |
Why?
|
| GTP-Binding Proteins | 1 | 2008 | 94 | 0.260 |
Why?
|
| Models, Theoretical | 3 | 2019 | 274 | 0.260 |
Why?
|
| Transcription Factors | 3 | 2024 | 1558 | 0.250 |
Why?
|
| Protein Interaction Mapping | 2 | 2016 | 69 | 0.230 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 431 | 0.230 |
Why?
|
| Nucleus Pulposus | 1 | 2025 | 1 | 0.230 |
Why?
|
| Annulus Fibrosus | 1 | 2025 | 1 | 0.230 |
Why?
|
| Intervertebral Disc | 1 | 2025 | 21 | 0.220 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2025 | 18 | 0.220 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1048 | 0.220 |
Why?
|
| Calcineurin | 1 | 2024 | 48 | 0.210 |
Why?
|
| Stress, Physiological | 2 | 2024 | 209 | 0.200 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 83 | 0.200 |
Why?
|
| Regeneration | 1 | 2025 | 123 | 0.200 |
Why?
|
| Adaptation, Physiological | 1 | 2024 | 131 | 0.200 |
Why?
|
| Spheniscidae | 1 | 2022 | 1 | 0.200 |
Why?
|
| Osteogenesis | 3 | 2025 | 151 | 0.190 |
Why?
|
| Tissue Scaffolds | 2 | 2025 | 90 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 219 | 0.190 |
Why?
|
| Ubiquitination | 2 | 2016 | 119 | 0.190 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 48 | 0.180 |
Why?
|
| Conservation of Natural Resources | 1 | 2022 | 44 | 0.180 |
Why?
|
| Mitochondria | 2 | 2024 | 404 | 0.180 |
Why?
|
| Tissue Engineering | 2 | 2025 | 147 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 313 | 0.180 |
Why?
|
| Hydrogels | 2 | 2021 | 125 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 311 | 0.170 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2019 | 62 | 0.170 |
Why?
|
| Bone Marrow | 1 | 2021 | 176 | 0.170 |
Why?
|
| Cell Differentiation | 4 | 2025 | 1394 | 0.160 |
Why?
|
| Drug Antagonism | 1 | 2020 | 9 | 0.160 |
Why?
|
| Intelligence | 1 | 2020 | 52 | 0.160 |
Why?
|
| Models, Neurological | 1 | 2020 | 82 | 0.160 |
Why?
|
| Beclin-1 | 1 | 2019 | 22 | 0.160 |
Why?
|
| Benchmarking | 1 | 2020 | 136 | 0.150 |
Why?
|
| Cell Line | 2 | 2021 | 2068 | 0.150 |
Why?
|
| Bioprinting | 1 | 2019 | 3 | 0.150 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2016 | 136 | 0.150 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 21 | 0.140 |
Why?
|
| Animals | 9 | 2025 | 21533 | 0.140 |
Why?
|
| Endosomes | 1 | 2019 | 180 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2019 | 223 | 0.140 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2018 | 14 | 0.140 |
Why?
|
| Coculture Techniques | 1 | 2018 | 103 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 881 | 0.140 |
Why?
|
| Quinolones | 1 | 2018 | 30 | 0.140 |
Why?
|
| Bibliometrics | 1 | 2018 | 34 | 0.140 |
Why?
|
| Journal Impact Factor | 1 | 2018 | 26 | 0.140 |
Why?
|
| Oligodendroglia | 1 | 2017 | 36 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2018 | 90 | 0.130 |
Why?
|
| Myelin Sheath | 1 | 2017 | 37 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2018 | 146 | 0.130 |
Why?
|
| Nerve Regeneration | 1 | 2017 | 38 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 49 | 0.130 |
Why?
|
| Precision Medicine | 1 | 2018 | 127 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 54 | 0.130 |
Why?
|
| Allosteric Site | 1 | 2016 | 31 | 0.120 |
Why?
|
| Growth Differentiation Factor 2 | 1 | 2016 | 2 | 0.120 |
Why?
|
| Disease Management | 1 | 2018 | 237 | 0.120 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 153 | 0.120 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 157 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 188 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 65 | 0.120 |
Why?
|
| Protein Domains | 1 | 2016 | 155 | 0.110 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2024 | 127 | 0.110 |
Why?
|
| Female | 6 | 2020 | 34115 | 0.110 |
Why?
|
| Chromatography, Gas | 1 | 2014 | 8 | 0.110 |
Why?
|
| Biotransformation | 1 | 2014 | 25 | 0.110 |
Why?
|
| Lignans | 1 | 2014 | 15 | 0.100 |
Why?
|
| Escherichia coli O157 | 1 | 2014 | 20 | 0.100 |
Why?
|
| Biphenyl Compounds | 1 | 2014 | 33 | 0.100 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 50 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 79 | 0.100 |
Why?
|
| Drug Resistance, Multiple | 1 | 2014 | 32 | 0.100 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 63 | 0.100 |
Why?
|
| Lipids | 1 | 2016 | 328 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2016 | 510 | 0.100 |
Why?
|
| Paclitaxel | 1 | 2014 | 104 | 0.100 |
Why?
|
| Intracranial Aneurysm | 1 | 2018 | 384 | 0.100 |
Why?
|
| Proteomics | 1 | 2015 | 306 | 0.100 |
Why?
|
| Crystallography, X-Ray | 1 | 2014 | 442 | 0.090 |
Why?
|
| Nanoparticles | 2 | 2019 | 545 | 0.090 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2012 | 5 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2014 | 187 | 0.090 |
Why?
|
| Brain | 1 | 2020 | 1606 | 0.090 |
Why?
|
| Caspase 8 | 1 | 2012 | 66 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 78 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 91 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 236 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 626 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 720 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2014 | 792 | 0.080 |
Why?
|
| Extracellular Matrix | 2 | 2022 | 146 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 257 | 0.080 |
Why?
|
| Erlotinib Hydrochloride | 2 | 2024 | 19 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2024 | 403 | 0.080 |
Why?
|
| Models, Biological | 2 | 2012 | 1217 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2014 | 1174 | 0.080 |
Why?
|
| Proteins | 1 | 2015 | 764 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1638 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2009 | 10 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2009 | 9 | 0.070 |
Why?
|
| Vacuoles | 1 | 2009 | 31 | 0.070 |
Why?
|
| Biocompatible Materials | 2 | 2021 | 153 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 793 | 0.070 |
Why?
|
| Chromatin | 1 | 2013 | 643 | 0.070 |
Why?
|
| Pheromones | 1 | 2008 | 22 | 0.070 |
Why?
|
| Mice | 5 | 2024 | 11209 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2019 | 630 | 0.060 |
Why?
|
| Chondrogenesis | 1 | 2025 | 11 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2004 | 7 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2025 | 49 | 0.060 |
Why?
|
| Calcium Chloride | 1 | 2024 | 19 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2004 | 108 | 0.050 |
Why?
|
| Cell Survival | 2 | 2018 | 600 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 46 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2024 | 130 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1216 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 180 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 242 | 0.050 |
Why?
|
| Antarctic Regions | 1 | 2022 | 3 | 0.050 |
Why?
|
| Introduced Species | 1 | 2022 | 2 | 0.050 |
Why?
|
| Biodiversity | 1 | 2022 | 47 | 0.050 |
Why?
|
| Climate Change | 1 | 2022 | 28 | 0.050 |
Why?
|
| Ecosystem | 1 | 2022 | 59 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 361 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2022 | 156 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 174 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 3788 | 0.040 |
Why?
|
| Insulin | 1 | 2024 | 694 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 2019 | 33 | 0.040 |
Why?
|
| Growth Differentiation Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 8 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2019 | 14 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 149 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 216 | 0.040 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 349 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 40 | 0.030 |
Why?
|
| Chitosan | 1 | 2019 | 87 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 147 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2018 | 83 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2019 | 152 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 209 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 468 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 350 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 523 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 528 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 440 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 53 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 458 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1218 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 877 | 0.030 |
Why?
|
| Quinazolines | 1 | 2014 | 22 | 0.030 |
Why?
|
| Receptors, Death Domain | 1 | 2014 | 1 | 0.030 |
Why?
|
| Allyl Compounds | 1 | 2014 | 4 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 38 | 0.030 |
Why?
|
| Liposomes | 1 | 2014 | 116 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2014 | 105 | 0.030 |
Why?
|
| Stents | 1 | 2018 | 502 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 713 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 74 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2013 | 17 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 9 | 0.030 |
Why?
|
| Acetylation | 1 | 2013 | 123 | 0.020 |
Why?
|
| Phenols | 1 | 2014 | 84 | 0.020 |
Why?
|
| Lysine | 1 | 2013 | 93 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 328 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 204 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 892 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 19 | 0.020 |
Why?
|
| Cellular Microenvironment | 1 | 2012 | 23 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 157 | 0.020 |
Why?
|
| DNA Repair | 1 | 2013 | 261 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 466 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 405 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 3355 | 0.020 |
Why?
|
| Histones | 1 | 2013 | 499 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 364 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6880 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 413 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 2680 | 0.010 |
Why?
|
| Male | 1 | 2017 | 31067 | 0.010 |
Why?
|